Detalles de la búsqueda
1.
Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancer.
Cancer
; 127(12): 1965-1973, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33690902
2.
Oncology education for family medicine residents: a national needs assessment survey.
BMC Med Educ
; 20(1): 283, 2020 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32854702
3.
DNA repair defects in prostate cancer: impact for screening, prognostication and treatment.
BJU Int
; 123(5): 769-776, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30281887
4.
Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Cancer
; 124(18): 3677-3683, 2018 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30307610
5.
177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: A Review of the Evidence and Implications for Canadian Clinical Practice.
Curr Oncol
; 31(3): 1400-1415, 2024 03 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38534939
6.
A Real-World Evidence Study Using Alberta-Population-Based Data to Describe Treatment Patterns for Metastatic Castration-Sensitive Prostate Cancer Patients (AWARENESS).
Curr Oncol
; 30(9): 8149-8158, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37754506
7.
Genetic testing practices among specialist physicians who treat prostate cancer A Canadian, cross-sectional survey.
Can Urol Assoc J
; 17(10): 326-336, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37494316
8.
Decreased ATM Protein Expression Is Substantiated with PTEN Loss in Defining Aggressive Phenotype of Prostate Cancer Associated with Lethal Disease.
Eur Urol Open Sci
; 29: 93-101, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34337539
9.
Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer.
Eur Urol
; 77(3): 333-341, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31640893
10.
Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations.
JAMA Netw Open
; 3(10): e2021692, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33112397
11.
Management of Medical Oncology Services in Canada: Redefined Workload With a Novel Supply-and-Demand Workforce Projection Model.
J Oncol Pract
; 14(7): e438-e445, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29996073
12.
Real-world Outcomes in Advanced Urothelial Cancer and the Role of Neutrophil to Lymphocyte Ratio.
Clin Genitourin Cancer
; 16(3): e637-e644, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29395946
13.
Cell-Free DNA Modification Dynamics in Abiraterone Acetate-Treated Prostate Cancer Patients.
Clin Cancer Res
; 24(14): 3317-3324, 2018 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29615462
14.
Considerations on the identification and management of metastatic prostate cancer patients with DNA repair gene alterations in the Canadian context.
Can Urol Assoc J
; 16(4): 132-143, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34812730
15.
Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC).
Kidney Cancer
; 1(1): 41-47, 2017 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30334003
16.
Review of the Interaction Between Body Composition and Clinical Outcomes in Metastatic Renal Cell Cancer Treated With Targeted Therapies.
J Kidney Cancer VHL
; 3(1): 12-22, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-28326276
Resultados
1 -
16
de 16
1
Próxima >
>>